Aditxt

Acquisition, funding and merger involving Aditxt.

• Aditxt has announced the acquisition of Appili Therapeutics  (posted on April 3 2024).
• Aditxt has announced the acquisition of Evofem Biosciences  (posted on December 14 2023).

View the org chart displaying its 13 main executives

Most searched biographies at Aditxt

• Amro Albanna, Chief Executive Officer
• Brian Brady, Director
• Jeffrey Runge, Director

Create your alert
to follow the executive moves at Aditxt.

Aditxt has 2,294 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Rapport Therapeutics has just announced a $100 Million fundraising (posted on May 20 2024).
• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Aditxt

• News
• Press Releases

Social media about Aditxt

• Aditxt on Wikipedia, Google News & Yahoo Finance
• Aditxt on LinkedIn, Twitter & YouTube

Contact by email its executives including Amro Albanna

Call Aditxt at +1 888...

View the org chart

Register to receive your alert

Report an error